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Positive/Negative Allosteric 
Modulation Switching in an Umami 
Taste Receptor (T1R1/T1R3) by 
a Natural Flavor Compound, 
Methional
Yasuka Toda1,2, Tomoya Nakagita1,3, Takatsugu Hirokawa4, Yuki Yamashita5, Ayako Nakajima5, 
Masataka Narukawa1, Yoshiro Ishimaru2, Riichiro Uchida5 & Takumi Misaka  1
Taste is a vital sensation for vertebrates, enabling the detection of nutritionally important substances 
or potential toxins. A heteromeric complex of two class C GPCRs, T1R1 and T1R3, was identified as the 
umami (savory) taste receptor. Amino acids and 5′-ribonucleotides are well known to be natural ligands 
for human T1R1/T1R3. In this study, we reveal that methional, which is a familiar flavor component 
in foods, is an allosteric modulator of T1R1/T1R3. Receptor expression experiments showed that 
methional served as a positive allosteric modulator (PAM) of human T1R1/T1R3 and functioned as a 
negative allosteric modulator (NAM) of mouse T1R1/T1R3. Although amino acids and 5′-ribonucleotides 
bound to the extracellular domain of T1R1, the use of interspecies chimeric receptors demonstrated 
that methional interacted with the transmembrane domain of T1R1. Site-directed mutagenesis 
and molecular modeling showed that methional could potentially bind at two distinct sites in the 
transmembrane domain of T1R1 and that the amino acid residues in the bottom of the allosteric 
pocket engendered the switch between the PAM and NAM modes, which could contribute to switching 
the binding position of methional. These results may be applicable for elucidating the molecular 
mechanisms underlying ligand recognition by other class C GPCRs.
As umami not only makes food palatable but also helps to reduce the NaCl levels in foods, the demand for novel 
modulators of umami taste has increased1. Through dozens of studies, various substances, such as peptides2, 
nucleotide derivatives3, and Maillard-reaction products4, were identified as umami molecules1. In vertebrates, 
umami taste is sensed by a heteromeric complex of two class C G-protein-coupled receptors (GPCRs), T1R1 and 
T1R35. Recently, there have been tremendous advances in the discovery of novel modulators for GPCRs that do 
not bind to the orthosteric ligand binding site but instead bind to an alternatively located binding site (allosteric 
site)6. Thus, we expected that there should be various allosteric modulators of human T1R1/T1R3 (hT1R1/hT1R3) 
among savory compounds that were discovered by sensory tests. However, only 5′-ribonucleotides, such as ino-
sine 5′-monophosphate (IMP) and guanosine 5′-monophosphate (GMP), as well as an artificial substance, “S807”, 
have been shown to interact with hT1R1/hT1R3 in an allosteric manner as umami molecules7. One of the reasons 
for this paucity of ligands is the difficulty of establishing a sensitive and accurate assay system for hT1R1/hT1R3.
Methional is a familiar flavor component in foods such as tomatoes8,9, cheese10,11, and soy sauce12. Although 
its meaty aroma has been reported to evoke an umami (savory) taste13,14, the effect of methional on the peripheral 
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taste system has not been elucidated. Here, we evaluated the activity of methional against hT1R1/hT1R3 using 
a cell-based high-throughput assay system that we previously established using calcium-sensitive photoprotein 
reporters15,16.
Results
Methional and its structural analogs act as allosteric/ago-allosteric modulators of human 
T1R1/T1R3. Humans have a strong umami taste response to monosodium glutamate and weak umami taste 
response to several other amino acids, such as monosodium aspartate and l-alanine (l-Ala)17. In accordance with 
these sensations, hT1R1/hT1R3 exhibits the strongest response to l-glutamate (l-Glu) among the proteinogenic 
amino acids5. Methional significantly enhanced responses to all 17 amino acids tested, except l-phenylalanine 
(p = 0.08), in hT1R1/hT1R3-expressing cells (Fig. 1a).
To identify the key chemical and structural features of methional for activating hT1R1/hT1R3, we examined 
seven structural analogs of methional (Fig. 1b–i). All of the analogs and methional were examined up to a con-
centration of 120 μM because the cellular responses were suppressed in a non-specific manner by methional 
and some analogs at higher concentrations. Among the seven analogs tested, neither methionol (2), 3-(meth-
ylthio)propionic acid (3), nor pentanal (4) enhanced l-Glu responses, suggesting that an aldehyde and alkylthio 
group are critical functional groups for activating hT1R1/hT1R3. 2-Methylthioacetaldehyde (5), 3-(ethylthio)
propanal (7), and 3-(methylthio)butanal (8) significantly enhanced l-Glu responses, while 4-(methylthio)buta-
nal (6) exhibited no significant effect. Among these active compounds, 3-(methylthio)butanal (8) and methional 
exhibited the strongest activities (Fig. 1j), suggesting that the optimum structure to activate hT1R1/hT1R3 is an 
aldehyde with a methylthio group at C-3.
Methional and 3-(methylthio)butanal (8) elicited weak but significant responses when applied alone to 
hT1R1/hT1R3-expressing cells (Fig. 1a,k). These results indicated that methional and 3-(methylthio)butanal (8) 
function as both PAMs and weak agonists for hT1R1/hT1R3. Methional and 3-(methylthio)butanal (8) enhanced 
l-Glu responses even when applied together with IMP (Fig. 2).
Identification of the determinant residues for methional activity in T1R1/T1R3. T1Rs often 
exhibit different ligand selectivity among vertebrate species5,18,19. Therefore, we next examined methional activity 
using mouse T1R1/T1R3 (mT1R1/mT1R3). As mT1R1/mT1R3 was only slightly activated by l-Glu, we instead 
used l-Ala, which is a potent agonist of the mouse receptor5,15. Intriguingly, methional significantly reduced l-Ala 
responses in mT1R1/mT1R3 (Fig. 3b-1). To dissect the molecular determinants that contributed to this unique 
interspecies difference, we examined the methional activity of the mixed receptor pair of human and mouse 
T1R1/T1R3. Methional acted as a PAM for human T1R1 paired with mouse T1R3 (Fig. 3b-2), showing that the 
T1R1 subunit is a crucial determinant of methional activity. T1Rs consist of three domains: a large extracellular 
VFTD, small extracellular cysteine-rich domain (CRD), and seven-transmembrane domain (TMD)20. To reveal 
which domain is crucial for switching PAM/NAM activities, we investigated human-mouse chimeric receptors 
by exchanging their TMDs. Methional served as a PAM for the heteromeric receptor in which the TMD of human 
T1R1 was introduced into mT1R1/mT1R3 (Fig. 3c-1). Conversely, methional acted as a NAM for the receptor in 
which the TMD of mouse T1R1 was introduced into hT1R1/mT1R3 (Fig. 3c-2). These data strongly suggest that 
the TMD of T1R1 is the key domain for switching the PAM/NAM activities of methional. Further analysis using 
chimeric receptors and point mutants identified four residues (h/m; F768/L769, N769/H770, S799/T800, and 
S802/G803) that, collectively, were sufficient to switch the PAM/NAM activities among the 52 non-conserved res-
idues between human and mouse T1R1-TMD (Fig. 4). Introducing four human amino acids at the corresponding 
positions of mouse T1R1 (“human-type mT1R1”; mT1R1-L769F, H770N, T800S, and G803S) completely con-
verted methional from a NAM to a PAM (Fig. 3d-1). In the case of human T1R1, introduction of three mouse 
amino acids (“mouse-type human T1R1”; hT1R1-F768L, S799T, and S802G) was sufficient to switch the action of 
methional from a PAM to a NAM (Fig. 3d-2).
Next, we sought to identify the residues that confer the PAM and NAM activities of methional by examin-
ing the corresponding residues that are crucial to the activities of either sweeteners (neohesperidin dihydro-
chalcone (NHDC) and cyclamate) and/or a sweet and umami taste inhibitor (lactisole) in human T1R321–23. 
As most of the target residues were identical between human and mouse T1R1 (Fig. 4), we introduced an ala-
nine mutation at each of these residues in hT1R1/mT1R3. Among the 32 residues that we examined, three point 
mutations (W697A, F728A, and F732A) completely abolished methional’s activity as a PAM, and another three 
mutations (L619A, G727A, and F777A) partially reduced this activity (Fig. 5a and Supplementary Table S1). In 
hT1R1-L619A, methional also caused a significant decrease in the efficacy (Emax) of l-Glu, while the other five 
alanine substitutions did not affect the efficacy of l-Glu (Supplementary Table S1). All six mutations also resulted 
in decreased activity of methional as an agonist of hT1R1/mT1R3, which was observed at a low concentration of 
l-Glu (Figs 3b-2 and 5a).
To examine whether these six residues also affected the activity of methional as a NAM, we introduced an 
alanine mutation at each of the corresponding residues in both wild-type mouse T1R1 and mouse-type human 
T1R1. In these mutant receptors paired with mouse T1R3, methional retained its activity as a NAM (Fig. 6a,b, 
and Supplementary Table S2), except in three receptors (mT1R1-L620A, mT1R1-G728A, and the mouse-type 
hT1R1 + L619A) that were nonfunctional in our assay and exhibited no detectable responses even to l-amino 
acids. Thus, to identify the residues that are crucial to NAM activity, we re-scanned all of the target residues by 
introducing an alanine mutation into the mouse-type hT1R1 in which methional served as a NAM (Fig. 3d-2). 
Although methional retained PAM activity in the corresponding mutant receptors of both wild-type hT1R1 and 
human-type mT1R1 (Fig. 6c,d, and Supplementary Table S1), the F642A mutation in mouse-type hT1R1 resulted 
in a loss of methional activity as a NAM and gain of activity as a weak PAM (Fig. 5b and Supplementary Table S2). 
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Figure 1. Methional and its structural analogs enhanced the responses of human T1R1/T1R3 to amino acids. 
(a) Methional enhanced the responses of hT1R1/hT1R3 to various amino acids. HEK293T cells coexpressing 
hT1R1/hT1R3 together with hG16gi3 were separately stimulated with 10 mM l-Glu or 50 mM concentrations 
of each amino acid except for l-Glu in the absence or presence of 120 μM methional. Significant differences 
between amino acid responses with and without methional were analyzed using Student’s t test (*p < 0.05; 
†p < 0.01; ‡p < 0.001). (b–i) Activities of methional and its structural analogs with respect to hT1R1/hT1R3. 
Dose-dependent responses to l-Glu were obtained in the presence and absence of 120 μM of methional 
and each of its analogs. Significant differences between l-Glu responses with and without methional or its 
analogs were analyzed using Student’s t test (*p < 0.05; †p < 0.01; ‡p < 0.001). (j) Dose-dependent responses 
to methional and its analogs were evaluated in the presence of 2 mM l-Glu. (k) 3-(Methylthio)butanal (8) 
behaved not only as a modulator but also as an agonist for hT1R1/hT1R3. HEK293T cells coexpressing hT1R1/
hT1R3 together with hG16gi3 were stimulated with 120 μM of each methional analog or IMP. Values represent 
the mean ± SE of the RLU (AUC) of 6 recorded wells. Significant differences from the response to buffer were 
analyzed using a one-way ANOVA followed by Dunnett’s test (‡p < 0.001).
www.nature.com/scientificreports/
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Alanine-scanning mutagenesis also revealed that two point mutations (F638A and W773A) in human T1R1 con-
verted methional from a PAM to a NAM (Fig. 5c and Supplementary Table S1).
Docking of methional to the TMD of T1R1. Based on the X-ray crystal structure of mGluR124, we created 
a homology model of the TMD of T1R1. As the template structure was bound to the NAM, we used mouse-type 
hT1R1, in which methional serves as a NAM, to construct the structural model (Fig. 3d-2). This model indi-
cated that all four residues that primarily contribute to switching the PAM/NAM activities of methional (L768, 
N769, T799, and G802 in the mouse-type hT1R1) (Fig. 3d) were clustered at the middle of the TMD (Fig. 7a). 
The NAM activity-conferring residue, F642 (Fig. 5b), was located near the PAM/NAM mode-switching site. By 
contrast, all six PAM activity-conferring residues (L619, W697, G727, F728, F732, and F777) (Fig. 5a) were posi-
tioned at the upper site of the TMD. Two residues, F638 and W773, for which alanine substitutions in hT1R1/
mT1R3 converted methional from a PAM to a NAM (Fig. 5c), were located at the border of the PAM and NAM 
activity-conferring sites.
We docked a methional molecule into our model using Glide software. All of the top 40 poses based on the 
Glide docking score showed that methional bound at the lower region of the allosteric pocket (Fig. 7a,b). These 
models showed that methional was located near the NAM activity-conferring residue that we identified, while 
most of the PAM activity-conferring residues were far from the docked position of methional. By contrast, among 
the top 50 poses, 8 lower-ranking poses indicated that methional could bind at a distinct site located in the upper 
region of the allosteric site (Fig. 7b).
To further evaluate binding site candidates, we compared the activities of structural analogs of methional 
when they acted as PAMs or NAMs. Although 3-(methylthio)butanal (8) was the strongest PAM for hT1R1/
mT1R3 (Fig. 7c and Supplementary Table S3) and hT1R1/hT1R3 (Fig. 1j), methional (1) exhibited the strongest 
NAM activity for mT1R1/mT1R3 (Fig. 7d). Similarly, 3-(methylthio)butanal (8) exhibited the strongest PAM 
activity for human-type mT1R1/mT1R3 (Fig. 7e), while methional (1) was the strongest NAM for mouse-type 
hT1R1/mT1R3 (Fig. 7f and Supplementary Table S3). The different affinities of the structural analogs between the 
PAM and NAM modes suggested that the binding positions of these modulators differ when they serve as PAMs 
or NAMs.
Discussion
In this study, we demonstrate that methional and its structural analogs serve as allosteric/ago-allosteric modu-
lators for T1R1/T1R3 through the contribution of widespread regions in the TMD of T1R1. There have been no 
reports on the molecular mechanisms underlying the allosteric modulation in the TMD of T1R1. By focusing on 
the unique species-dependent difference in the methional activity, we could reveal the mechanism of the positive 
and negative modulation in T1R1.
As methional has a pleasant meaty and soup-like flavor25, its aroma has been reported to evoke an umami sen-
sation via a cross-modal interaction between taste and smell13,14. However, our results demonstrate that methional 
directly affected umami taste via peripheral gustatory receptors in addition to its effects via the olfactory system. 
Recently, Suess et al. also reported that an odorant reduced the bitterness of caffeine by interacting with bitter 
taste receptors (TAS2Rs)26.
Figure 2. Methional and 3-(methylthio)butanal (8) enhanced l-Glu responses in the presence of IMP. (a) 
HEK293T cells coexpressing hT1R1/hT1R3 together with hG16gi3 were stimulated with 2 mM l-Glu in the 
absence or presence of 120 μM methional (1), 120 μM IMP, or both. (b) HEK293T cells coexpressing hT1R1/
hT1R3 together with hG16gi3 were stimulated with 2 mM l-Glu in the absence or presence of 120 μM 
3-(methylthio)butanal (8), 120 μM IMP, or both. Values represent the mean ± SE of the RLU(AUC) of 6 
recorded wells. Means followed by a different letter are significantly different, as analyzed by Tukey’s test 
(p < 0.05).
www.nature.com/scientificreports/
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Analysis of structural analogs suggested that the optimum structure to activate hT1R1/hT1R3 is an aldehyde 
with a methylthio group at C-3 (Fig. 1). Although 5′-ribonucleotides do not activate hT1R1/hT1R3 on their own5, 
methional and 3-(methylthio)butanal (8) function as both PAMs and weak agonists for hT1R1/hT1R3 (Fig. 1a,k). 
Figure 3. Identification of residues that engendered a switch in the PAM/NAM mode of methional activity. 
(a) T1R1 chimeras were designed to contain human (gray) and mouse amino acid sequences (white). (b–d) 
Dose-dependent responses to l-Ala (b-1,c-1,d-1) or l-Glu (b-2,c-2,d-2) were obtained for each T1R1 paired 
with mouse T1R3. Significant differences between amino acid responses with and without 120 μM methional 
were analyzed using Student’s t test (*p < 0.05; †p < 0.01; ‡p < 0.001). Values represent the mean ± SE of the 
RLU(AUC) of 6 recorded wells. The EC50 and Emax values of hT1R1/mT1R3 (b-2) and of mouse-type hT1R1/
mT1R3 (d-2) are shown in Supplementary Tables S1 and S2, respectively.
www.nature.com/scientificreports/
6SCienTiFiC REPORTS |  (2018) 8:11796  | DOI:10.1038/s41598-018-30315-x
Methional and 3-(methylthio)butanal (8) can enhance l-Glu responses even when applied together with IMP 
(Fig. 2), implying that their binding site is distinct from that of IMP, which is located within the extracellular 
Venus flytrap domain (VFTD) of T1R17.
To our knowledge, methional is the first-known compound that acts as both a PAM for the human taste recep-
tor and NAM for the rodent receptor (Fig. 3). Analysis using chimeric receptors and point mutants demonstrated 
that the TMD of T1R1 is the key domain for switching the PAM/NAM activities of methional and identified four 
residues (h/m; F768/L769, N769/H770, S799/T800, and S802/G803) that were collectively sufficient to switch 
PAM/NAM activities (Fig. 3). A similarly drastic mode change in allosteric modulator activity has been reported 
in site-directed mutagenesis studies of a related GPCR, metabotropic glutamate receptor 5 (mGluR5)27,28. N769 
Figure 4. Sequence alignment of the TMD of human mGluR1, rat mGluR5, human T1R1, mouse T1R1, 
and human T1R3. Amino acid sequences around TM2 to TM7 are shown. The residues that were mutated in 
this study are framed by colored lines. The residues conferring PAM activity are outlined in magenta, those 
conferring NAM activity are outlined in blue, those responsible for PAM/NAM mode switching are outlined in 
yellow, and those responsible for the microswitch of receptor activation are outlined in green. The residues that 
did not show significant effects are in black. The residues that have been reported to be crucial for the activities 
of sweeteners and/or an inhibitor of human T1R3 are marked below the amino acid sequences with triangles 
(NHDC), circles (cyclamate), and squares (lactisole)21.
www.nature.com/scientificreports/
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and S799 in human T1R1 correspond to the residues in rat mGluR5 (Fig. 4) in which the introduction of an 
alanine mutation converted its PAMs to NAMs27. Moreover, S799 and S802 in human T1R1 correspond to the 
residues in T1R3 that reportedly contribute to the activities of sweeteners (NHDC and cyclamate) and/or a sweet 
taste inhibitor (lactisole) (Fig. 4)21–23. Winnig et al. proposed that C801 in T1R3, which corresponds to S799 in 
human T1R1 (Fig. 4), plays a general role in the activation process of the sweet taste receptor rather than directly 
interacting with ligands because it is far from the binding site of lactisole23. Thus, we hypothesize that the four 
Figure 5. Residues that conferred the PAM and NAM activities of methional in T1R1. Dose-response curves 
were obtained to l-Glu for each human T1R1 mutant paired with mouse T1R3. (a) Of the 32 residues examined 
(Fig. 4), an alanine substitution in each of the six residues in hT1R1 caused either an abolition or a decrease 
in the PAM activity of methional. (b) An alanine substitution in mouse-type hT1R1 caused a decrease in the 
NAM activity of methional. (c) An alanine mutation in each of two residues in hT1R1 swapped the PAM and 
NAM activity of methional. Values represent the mean ± SE of the RLU (AUC) of 6 recorded wells. Significant 
differences between l-Glu responses with and without 120 μM methional were analyzed using Student’s t 
test (*p < 0.05; †p < 0.01; ‡p < 0.001). The EC50 and Emax values of the receptors described here are shown in 
Supplementary Table S1 (a,c) and Table S2 (b), respectively.
www.nature.com/scientificreports/
8SCienTiFiC REPORTS |  (2018) 8:11796  | DOI:10.1038/s41598-018-30315-x
residues identified here mainly affect a global conformation of T1R1/T1R3 that induces the PAM/NAM mode 
switch rather than directly interacting with methional.
To identify the residues that confer the PAM and NAM activities of methional, we performed alanine-scanning 
mutagenesis of the corresponding residues that are crucial to the activities of NHDC, cyclamate, and lactisole in 
human T1R3. As a result, we identified six residues (L619, W697, G727, F728, F732, and F777 in hT1R1) that 
confer the PAM activity of methional (Fig. 5a). These results validate our hypothesis that different sets of residues 
contribute to either engendering the PAM/NAM mode switch or conferring the PAM/NAM activity of methional. 
Moreover, these residues did not affect the activity of methional as a NAM (Fig. 6a,b, and Supplementary 
Table S2), implying that additional residues contribute to imparting the NAM activity of methional. In fact, 
alanine-scanning mutagenesis using the mouse-type hT1R1 identified that F642 is crucial to the NAM activ-
ity (Fig. 5b and Supplementary Table S2), but did not affect the PAM activity of methional (Fig. 6c,d, and 
Supplementary Table S1). These results suggest that both the PAM and NAM activities of methional are conferred 
by residues that are distinct from those engendering the PAM/NAM mode switch.
A homology model of the TMD of mouse-type hT1R1 indicated that all four residues that primarily contrib-
ute to switching the PAM/NAM activities of methional (L768, N769, T799, and G802 in the mouse-type hT1R1) 
are clustered at the middle of the TMD (Fig. 7a). This position is at the bottom edge of the putative allosteric 
binding site, which was predicted by alignment with other GPCRs21–24. The NAM activity-conferring residue 
F642 (Fig. 5b) is located near the PAM/NAM mode-switching site. By contrast, all six PAM activity-conferring 
residues (L619, W697, G727, F728, F732, and F777) (Fig. 5a) are positioned at the upper site of the TMD. L619 
Figure 6. Distinct sets of residues conferred either the PAM or NAM activity of methional. (a,b) The residues 
described in Fig. 5a did not affect the activity of methional as a NAM. Dose-dependent responses were obtained 
to l-Ala for each mouse T1R1 mutant (a) and to l-Glu for each mouse-type human T1R1 mutant (b) paired 
with mouse T1R3. (c,d) The residue described in Fig. 5b did not affect the activity of methional as a PAM. Dose-
dependent responses were obtained to l-Glu for the human T1R1 mutant (c) and to l-Ala for the human-type 
mouse T1R1 mutant (d) paired with mouse T1R3. Significant differences between l-amino acid responses with 
and without 120 μM methional were analyzed using Student’s t test (*p < 0.05; †p < 0.01; ‡p < 0.001). Values 
represent the mean ± SE of the RLU (AUC) of 6 recorded wells. The EC50 and Emax values of the receptors 
described in b and c are shown in Supplementary Tables S1 and S2, respectively.
www.nature.com/scientificreports/
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is located away from the other five residues, possibly explaining its different contribution to the efficacy of l-Glu 
(Fig. 5a and Supplementary Table S1). Two residues, F638 and W773, for which alanine substitutions in hT1R1/
mT1R3 converted methional from a PAM to a NAM (Fig. 5c), are located at the border of the PAM and NAM 
Figure 7. Widespread areas engendering the PAM/NAM activities of methional. (a,b) Two distinct putative 
binding sites for methional. A methional molecule docked into the homology model of the transmembrane 
domain of mouse-type hT1R1. The residues that confer PAM activity are represented in magenta, those that 
confer NAM activity are represented in blue, and those that contribute to PAM/NAM mode-switching are 
represented in yellow. Two residues in which an alanine substitution changed the activity of methional from 
that of a PAM to that of a NAM are represented in green. The residues are also numbered according to the 
Ballesteros-Weinstein numbering scheme29. A representative docking pose with the highest Glide docking score 
is shown (a). Methional is shown as a space-filling model. All of the top 50 poses, ranked by the Glide docking 
score, are superimposed and displayed, and methional molecules are shown in black (b). All of the 40 top poses 
showed that methional binds to the lower region of the allosteric pocket, while 8 of the top poses ranked from 
41 to 50 suggested a binding site in the upper region of the allosteric pocket. The dotted red circles represent the 
upper and lower putative binding regions of methional. (c–f) Methional was the strongest NAM for the mouse-
type T1R1 receptor, while 3-(methylthio)butanal (8) was the strongest PAM for the human-type receptor. Dose-
dependent responses to l-Glu (c,f) or l-Ala (d,e) were obtained in the presence and absence of methional and 
each of its analogs (120 μM). Values represent the mean ± SE of the RLU (AUC) of 6 recorded wells. The EC50 
and Emax values of the receptors described in c and f are shown in Supplementary Table S3.
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activity-conferring sites. W773 (W6.48 numbered according to the system of Ballesteros and Weinstein29) is 
widely conserved among GPCRs and is thought to function as a transmission switch for receptor activation30. 
Moreover, the Phe residue that faces W6.48 in TM-3 has been reported to act as a key switch residue in the acti-
vation process of a class A GPCR, the cannabinoid CB1 receptor31. Our mutagenesis experiment also suggested 
that W6.48 and the Phe residue in the TM-3 function as a microswitch to activate T1R1/T1R3, which is induced 
by a modulator that interacts with the TMD.
The docking models suggested two putative binding sites for methional at the upper and lower regions of 
the allosteric pocket (Fig. 7b). Because a crystal structure of the TMD in complex with a PAM is not currently 
available for class C GPCRs, we could not fully define the docked pose of methional as a PAM. However, taken 
together with the results that PAM activity-conferring residues were clustered in the upper region of the allosteric 
site, these data suggest that this upper area is a potential binding site for methional when it serves as a PAM. The 
binding pocket consists of many hydrophobic residues that face inside, and most of the crucial residues to the 
methional activity were also hydrophobic amino acids (Fig. 7). Methional is amphiphilic compound and its LogP 
value is −0.16. Therefore, there is a strong possibility that methional binds to both the upper and lower regions 
of the TMD of T1R1. Additionally, 3-(methylthio)butanal (8) is hypothesized to bind at the upper binding site 
rather than the lower site because it was the bulkiest analog used in this study. This is likely one of the reasons 
why 3-(methylthio)butanal (8) acts as a strong PAM for human T1R1/T1R3 but a weak NAM for mouse T1R1/
T1R3 (Fig. 7c–f). As an alanine mutation at each of PAM activity-conferring residues also resulted in decreased 
activity of methional as an agonist (Figs 3b-2 and 5a), methional could also bind at the same upper binding site 
as when it served as a PAM.
Owing to the small molecular size of methional, we could not assume that the residues that we identified 
either coordinate a direct interaction with methional or have a global effect on protein conformations for 
engendering active/negative conformations. However, our data may suggest an attractive mechanism by which 
a small-molecule compound, methional, is endowed with PAM/NAM activities by widespread regions in the 
allosteric site that have distinct effects on the activity of methional. Two distinct putative binding sites for 
methional exist across the microswitch for receptor activation, and the residues at the bottom of the allosteric 
site might contribute to switching the binding positions of methional (Fig. 8). GPCRs are involved in most 
pathophysiological processes and are the targets of many therapeutic agents32. These findings could contribute to 
understanding the molecular basis of the allosteric modulations in T1Rs and other GPCRs.
Methional has been used as an essential flavor additive for various processed foods, such as gravies, meat 
products, baked goods, and condiments, at a wide range of concentrations (0.6–120 μM)25. Our results suggest 
that the widespread use of methional might be due not only to its pleasant aroma but also its preferable effect on 
the sensation of umami taste.
In addition to the use of methional as a food additive, various foods naturally contain methional via degrada-
tion of methionine25. Foods that are used globally as seasonings, such as tomatoes8,9, cheese10,11, and soy sauce12, 
commonly contain methional as one of their main flavor components. Among the structural analogs that we 
used, 2-methylthioacetaldehyde (5) and 3-(methylthio)butanal (8) are also reported in natural products, such 
as tomatoes and krill25. Our receptor assay showed that methional activated T1R1/T1R3 in conjunction with 
other umami tastants, such as amino acids and 5′-ribonucleotides (Fig. 2). In fact, these foods also commonly 
contain high concentrations of l-Glu33, which is the most common substance conferring an umami taste for 
humans. Moreover, the concentration of methional is higher in heated than fresh tomatoes34. Thus, in coopera-
tion with amino acids and 5′-ribonucleotides, methional could contribute to enhancing the umami taste of our 
meals through cooking.
Methods
Materials. Samples were obtained from commercial sources as follows: l-aspartic acid sodium salt, l-glu-
tamic acid monosodium salt, l-serine, l-lysine monohydrochloride, l-histidine monohydrochloride monohy-
drate, l-proline, and l-phenylalanine were purchased from Nacalai Tesque; l-glutamine, l-threonine, glycine, 
l-alanine, l-valine, l-isoleucine, l-leucine, l-arginine, and l-asparagine monohydrate were obtained from Kanto 
Chemical; l-methionine, methionol, pentanal, 3-(methylthio)propionic acid, and 3-(methylthio)butanal were 
obtained from Tokyo Chemical Industry; methional was from Sigma Aldrich; 2-methylthioacetaldehyde was 
from Penta Manufacturing Company; 3-(ethylthio)propanal was from Enamine Ltd.; 4-(methylthio)butanal was 
from FCH Group; and coelenterazine was purchased from Promega.
Constructs for Human-Rodent Chimeric Taste Receptors and their Point Mutants. hT1R1 (NCBI 
RefSeq number NM_138697.3), hT1R3 (NM_152228.1), mT1R1 (NM_031867.2), mT1R3 (NM_031872.2), 
human-mouse T1R1 chimeras, and point mutants of hT1R1 and mT1R1 were constructed by polymerase chain 
reaction (PCR) using overlapping primers as previously described15 and were subcloned into the pEAK10 expres-
sion vector (Edge Biosystems) at the Asc I-Not I site. The Kozak consensus sequence was introduced upstream 
of the start codon for efficient translation. For alanine scanning mutagenesis, targeted alanine residues were 
mutated to other bulky or charged amino acids (hT1R1-A639V, hT1R1-A639H, hT1R1-A731V, hT1R1-A731E, 
hT1R1-A780V, hT1R1-A780Y, and hT1R1-A795L).
Luminescence-based Assay for T1R1/T1R3. T1R responses were measured in heterologous cells using a 
luminescence-based assay, as previously described15. HEK293T cells were transiently co-transfected with expres-
sion vectors for T1R1, T1R3, hG16gi3, and mt-apoaequorin and, after 48 h of transfection, exposed to test stimuli 
and assayed for luminescence. Methional and its analogs were dissolved in DMSO to 240 mM and then diluted 
to their desired concentrations in assay buffer. Control solutions were prepared by matching the DMSO concen-
tration to that of the test solutions. The response from each well was calculated based on the area under the curve 
www.nature.com/scientificreports/
1 1SCienTiFiC REPORTS |  (2018) 8:11796  | DOI:10.1038/s41598-018-30315-x
(AUC) and is expressed as relative light units (RLU). For receptors in which the responses to l-amino acids were 
saturated at the highest concentration tested (50 mM), plots of the amplitudes versus concentrations were fitted 
to the Hill equation, and the EC50 values and Emax values were evaluated (Supplementary Table S1, S2, and S3). 
Statistical analysis was performed using Student’s t-test and one-way ANOVA followed by Tukey’s test using the 
software Ky Plot version 3.0.
Homology Model Development. A homology model of the mouse-type human T1R1 was created using 
Prime (Schrödinger, LLC) and based on an inactive form of the metabotropic glutamate receptor 1 (mGluR1) 
(PDB ID: 4OR2), which is one of the most closely related receptors to the T1Rs24.
Glide Docking of Methional. The SiteMap program (Schrödinger, LLC) was used to initially identify 
two potential ligand binding sites for the mouse-type human T1R1; one was near the three mutated residues 
at the bottom of the binding site, and the other was in the upper region of the allosteric pocket. Glide dock-
ing (Schrödinger, LLC) was then performed to allow methional to explore both of these potential binding sites. 
Standard precision (SP) mode and the OPLS3 force field were used during docking.
Data availability. All data generated or analyzed during this study are available from the corresponding 
author on reasonable request.
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